1. 1845PSafety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials. (23rd October 2018) Authors: Mau-Sorensen, M; van Bussel, M; Kuipers, M; Nielsen, D L; Verheul, H M; Aftimos, P; de Jonge, M J A; van Triest, B; Falkenius, J; Debus, J; Troost, E; Samuels, M; Sarholz, B; Budach, V; Goel, S; Locatelli, G; Geertsen, P F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 433PAn open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics of oral administration of irinotecan in adult patients with solid tumors. (23rd October 2018) Authors: Palshof, J A; Kümler, I; Sørensen, P G; Jensen, B V; Nielsen, D L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 518PHepatic arterial infusion (HAI) of oxaliplatin with capecitabine in first line treatment of patients (pts) with liver limited metastases from colorectal cancer (LLmCRC). (23rd October 2018) Authors: Vittrup, B V; Nørgaard, H H; Bergenfeldt, M; Larsen, F O; Høgdall, E; Johansen, J S; Sidenius Johansen, J S; Hermann, H K; Nielsen, D L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 556PCell free DNA and hepatic arterial infusion of oxaliplatin plus systemic capecitabine for patients with colorectal cancer liver metastases. (23rd October 2018) Authors: Boysen, A K; Schou, J V; Jensen, B V; Nielsen, D L; Sørensen, B S; Johansen, J S; Spindler, K-L G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients: The ReCap Study. (9th February 2022) Authors: Lund, Cecilia Margareta; Mikkelsen, M K; Theile, S; Michelsen, H M; Schultz, M; Sengeløv, L; Nielsen, D L Journal: Oncologist Issue: Volume 27:Number 2(2022) Page Start: e185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗